Chlorodehydromethyltestosterone (Turinabol) 10 mg Cygnus

£62.00

SKU: CYG-PK-0087 Categories: ,

Description

Product Description: Chlorodehydromethyltestosterone (Turinabol) 10 mg Cygnus

Chlorodehydromethyltestosterone (Turinabol) 10 mg Cygnus is a high-quality anabolic steroid specifically designed to enhance athletic performance and aid bodybuilders in achieving their fitness goals. With its unique composition and potent properties, this product offers numerous benefits for athletes seeking to improve their strength, endurance, and muscle mass.

Features and Benefits

  • Enhanced Muscle Growth: Turinabol promotes protein synthesis, leading to increased muscle mass and strength gains.
  • Improved Performance: This steroid enhances oxygen-carrying capacity, resulting in enhanced endurance and stamina during intense workouts.
  • Reduced Fatigue: Turinabol helps athletes recover faster from intense training sessions, reducing fatigue and allowing for more frequent and productive workouts.
  • Lean Muscle Definition: By reducing water retention and promoting fat loss, this product helps athletes achieve a more defined and sculpted physique.
  • Minimal Estrogenic Effects: Turinabol has low estrogenic activity, minimizing the risk of estrogen-related side effects such as gynecomastia.

Possible Side Effects

While Turinabol is generally well-tolerated, it is important to be aware of potential side effects, including:

  • Liver Toxicity: Like most oral steroids, Turinabol can strain the liver. It is recommended to use liver support supplements and follow proper dosage guidelines.
  • Androgenic Effects: Some individuals may experience androgenic side effects such as acne, oily skin, and hair loss.
  • Suppression of Natural Testosterone Production: Prolonged use of Turinabol may suppress natural testosterone production. Post-cycle therapy is recommended to restore hormonal balance.

Methods of Use and Dosage for Bodybuilders

For bodybuilders, the recommended dosage of Turinabol is typically 20-50 mg per day. It is important to start with a lower dosage and gradually increase it to assess individual tolerance and minimize potential side effects. The cycle duration usually ranges from 6 to 8 weeks.

Indications and Contraindications

Turinabol is indicated for athletes and bodybuilders seeking to enhance their performance, increase muscle mass, and improve physical appearance. However, it is important to note that this product is not suitable for everyone. It is contraindicated for individuals with the following conditions:

  • Prostate or breast cancer
  • High blood pressure
  • Liver or kidney disease
  • Heart conditions
  • Allergies to any of the product’s ingredients

Value to the Buyer

By purchasing Chlorodehydromethyltestosterone (Turinabol) 10 mg Cygnus from our website buysteroids-uk.com, you can enjoy several advantages:

  • Authentic and High-Quality Product: We guarantee the authenticity and quality of all our products, ensuring optimal results for athletes.
  • Discreet Packaging: Your privacy is important to us. We provide discreet packaging to protect your confidentiality.
  • Secure Online Shopping: Our website offers a secure and user-friendly platform for convenient and safe online shopping.
  • Fast and Reliable Shipping: We strive to deliver your order promptly and reliably, ensuring a seamless buying experience.
  • Responsive Customer Support: Our dedicated customer support team is available to assist you with any inquiries or concerns you may have.

Choose buysteroids-uk.com as your trusted source for Chlorodehydromethyltestosterone (Turinabol) 10 mg Cygnus and take your athletic performance to new heights!

Additional information

Active ingredient

Turinabol

Wirkstoff, mg

10

Form der Produktion

Tabletten

1 tablet, mg

10

Blister, Tabletten

2, 50

Hersteller

Cygnus pharmaceuticals group

Verpackung der produkte

Verpackung (2 blister)

Reviews

There are no reviews yet.

Be the first to review “Chlorodehydromethyltestosterone (Turinabol) 10 mg Cygnus”

Your email address will not be published. Required fields are marked *